Clinical

Dataset Information

Experimental Therapeutic Cancer Vaccine Created In-situ in Patients With Stage II-Stage IV Cancer


ABSTRACT: A Phase I/II study of an in-situ therapeutic cancer vaccine. Vaccines contain a source of antigen and and adjuvant. In this study the source of tumor antigen comes from the killing of a selected tumor by cryoablation (killing using extreme cold) and the adjuvant is intentionally mis-matched immune cells (AlloStim-TM) engineered to produce inflammatory cytokines.

DISEASE(S): Ovarian Cancer,Prostatic Neoplasms,Sarcoma,Melanoma,Colorectal Cancer,Non-small Cell Lung Cancer,Colorectal Neoplasms,Prostate Cancer,Ovarian Neoplasms,Breast Cancer,Solid Tumors Stage Ii, Stage Iii And Stage Iv

PROVIDER: 2084684 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR